Journal of Clinical Investigation - JCI INSIGHT: JAK inhibitors reverse hair loss in alopecia areata There are few treatments available to prevent and reverse hair loss associated with alopecia areata, a common
![Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/79/5/674/F1.large.jpg)
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases
![Janus kinase inhibitors: An innovative treatment for alopecia areata - Park - 2019 - The Journal of Dermatology - Wiley Online Library Janus kinase inhibitors: An innovative treatment for alopecia areata - Park - 2019 - The Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/16fd57ac-6410-430a-b234-d714cd25f29d/jde14986-fig-0002-m.jpg)
Janus kinase inhibitors: An innovative treatment for alopecia areata - Park - 2019 - The Journal of Dermatology - Wiley Online Library
![Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/04339364fc49b7c4a495af383707809cd97f0686/2-Figure1-1.png)
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar
![Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib | HTML | Acta Dermato-Venereologica Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/html-img/5738/5738_24893.png)
Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib | HTML | Acta Dermato-Venereologica
![Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine](https://www.thelancet.com/cms/asset/43327719-6a33-431f-b355-9c5caf7dcc6a/gr1.jpg)